The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which she experienced when taking opioids.

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...

"Faux-tox" or fake botox is popping up across the country. With the allure of younger looking skin at discounted prices and through third parties, professionals are sending a warning about ...

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...

A 5-year-old boy from Royal Oak was killed in an explosion while receiving hyperbaric oxygen therapy at a healthcare facility ...

Pennsylvania is one of nine states that are currently being impacted by a chocolate recall. And that recall has just reached ...